Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Christopher KennardEmeritus Professor of Clinical Neurology, Professor Christopher Kennard joins the Medical Sciences Division as its new interim Head of Division today, replacing Professor Alastair Buchan, who will be taking a new role as the University’s Head of Brexit Strategy. Professor Kennard knows the Division well, having served, until his retirement late last year, as the Head of the Nuffield Department of Clinical Neuroscience, one of the 16 departments within the Division. Prior to his arrival in Oxford, Prof Kennard was the Deputy Principal for the Faculty of Medicine at Imperial College, London.

Professor Christopher Kennard commented:  “It is a great honour to have been invited by the VC to take on the role of interim Head of the Medical Sciences Division, following Alastair Buchan’s move to become the Head of Brexit Strategy for the University. During his nine year tenure he successfully led the Division to its premier international position and made major contributions in many areas. I very much look forward to being able to contribute to the Division’s continuing success and to work with such an exceptionally talented group of teachers and researchers.”

Professor Louise Richardson, Vice-Chancellor, said: “I am deeply grateful to Professor Christopher Kennard for agreeing to assume the role of Head of Division on an interim basis until a new Head of Division is appointed. The Division sought Council’s approval for the process of selecting a new Head of Division, and we expect to have a new head in place before Professor Alastair Buchan’s term would ordinarily have concluded.”

Similar stories

Labelling proteins through the diet gives new insights into how collagen-rich tissues change as we age

A new study, published in eLife, uses advanced tissue analysis technology to show how the incorporation of new proteins changes in bone and cartilage with age.

Drug could help diabetic hearts recover after heart attack - Oxford research

Researchers at the University of Oxford have identified a drug that could ultimately help improve heart function in people with diabetes who have heart attacks.

Largest ever global study of tuberculosis identifies genetic causes of drug resistance

Using cutting-edge genomic sequencing techniques, researchers at the University of Oxford have identified almost all the genomic variation that gives people resistance to 13 of the most common tuberculosis (TB) drug treatments.

Peter Horby receives prestigious award for outstanding service to public health

The Faculty of Public Health (FPH) has awarded its prestigious Alwyn Smith Prize to Professor Sir Peter Horby (Nuffield Department of Medicine) for 2020/2021 in recognition of his outstanding service to public health as a global leader in epidemic science.

Six new Fellowships announced as part of Oxford-Bristol Myers Squibb Fellowships Programme

The Oxford - Bristol Myers Squibb (BMS) Fellowships Programme continued to demonstrate significant progress over the last year, despite the challenges associated with the global pandemic, including restricted lab access and work from home guidance. Today, we are pleased to announce six new Oxford-BMS Fellowships for 2021.

Researchers set out steps to address mental health effects of the pandemic on young people

Researchers have outlined 14 steps that schools, mental health services and policymakers can take to help children and young people whose mental health has been affected by the COVID-19 pandemic.